Abstract
Background
A short-term randomized controlled trial shows that the one anastomosis gastric bypass (OAGB) is a safe and effective alternative to the Roux-en-Y gastric bypass (RYGB).
Objective
The aim of this study is to evaluate the OAGB at our University Hospital between 2006 and 2013.
Patients
One thousand patients have undergone an OAGB. Data were collected on all consecutive patients. The mean follow-up period was 31 months (SD, 26.3; range, 12–82.9), and complete follow-up was available in 126 of 175 patients (72 %) at 5 years after surgery.
Results
Mortality rate was 0.2 %. Overall morbidity was 5.5 %; 34 required reoperations: i.e., 6 leaks, 5 obstructions, 5 incisional hernias, 7 biliary refluxes, 2 perforated ulcers, 2 bleeds, 2 abscesses, and 1 anastomotic stricture. Four patients were reoperated for weight regain. Overall rate of marginal ulcers was 2 % (n = 20), all in heavy smokers. Conversion from an OAGB to a RYGB was required in nine cases (0.9 %): seven for intractable biliary reflux, two for a marginal ulcer. At 5 years, percent excess body mass index loss was 71.6 ± 27 %. One hundred patients with type-2 diabetes, with a mean preoperative HbA1C of 7.7 ± 1.9 %, were followed for >2 years; the total resolution rate was 85.7 %.
Conclusion
This study confirms that the OAGB is an effective procedure for morbid obesity with comparable outcomes to RYGB; in addition, it seems to be safer with lower morbidity. Its technical simplicity represents a real advantage and makes it an option that should be considered by all bariatric surgeons.
Similar content being viewed by others
References
Sjostrom L, Narbro K, Sjostrom D, et al. Effect of bariatric surgery on mortality in Swedish obese subjects. NEJM. 2007;357:741–52.
Balsiger BM, Poggio JL, Kelly KA, et al. Ten and more years after vertical banded gastroplasty as primary operation for morbid obesity. J Gastrointest Surg. 2000;4:598–605.
Chevallier JM, Païta M, Rodde-Dunet MH, et al. Predictive factors of outcome after gastric banding: a nationwide survey on the role of center activity and patient’s behavior. Ann Surg. 2007;246:1034–9.
Lönroth H, Dalenbäck J, Hagling E, et al. Laparoscopic gastric bypass. Surg Endosc. 1998;10:636–8.
Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity. Ann Surg. 2005;242:20–8.
Fisher BL, Buchwald H, Clark W, et al. Mini-gastric bypass controversy. Obes Surg. 2001;11:773–7.
Carbajo M, Garcia-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15(3):398–404.
Noun R, Skaff J, Riachi E, et al. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22(5):697–703.
Lee WJ, Ser KH, Lee YC, et al. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22(12):1827–34.
Musella M, Susa A, Greco F, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multicenter review. Surg Endosc. 2014;28(1):156–63.
Kular KS, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses- first study from Indian subcontinent. Obes Surg. 2014;24:1430–5.
Chevallier JM, Zinzindohoué F, Douard R, et al. Complications after laparoscopic adjustable gastric banding for morbid obesity: experience with 1000 patients over 7 years. Obes Surg. 2004;14:407–14.
Chakhtoura G, Zinzindohoué F, Ghanem Y, et al. Chevallier JM primary results of laparoscopic mini-gastric bypass in a French obesity-surgery specialized university hospital. Obes Surg. 2008;18:1130–3.
Deitel M, Gawdat K, Melissas J. Reporting weight loss 2007. Obes Surg. 2007;17:565–8.
Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187–96.
Rutledge R. The mini-gastric bypass: experience with the first 1,274 cases. Obes Surg. 2001;11:276–80.
Schauer P, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.
Schauer P, Ikramuddin S, Hamad G, et al. The learning curve for laparoscopic Roux-en-Y gastric bypass is 100 cases. Surg Endosc. 2003;17(2):212–5.
Su-Hsin C, Stoll C, Jihyun S, et al. The effectiveness and risks of bariatric surgery, an updates systematic review and meta-analysis. JAMA Surg. 2014;149(3):275–87.
Hwang RF, Swartz DE, Felix EL. Causes of small bowel obstruction after laparoscopic gastric bypass. Surg Endosc. 2004;18(11):1631–5.
Jacobsen HJ, Nergard BJ, Leifsson BG, et al. Management of suspected anastomotic leak after bariatric laparoscopic Roux-en-Y gastric bypass. Br J Surg. 2014;101:417–23.
Higa K, Ho T, Boone K. Internal hernias after laparoscopic Roux-en-Y gastric bypass: incidence, treatment and prevention. Obes Surg. 2003;13:350–4.
Dillemans B, Sakran N, Van Cauwenberge S, et al. Standardization of the fully stapled laparoscopic Roux-en-Y gastric bypass for obesity reduces immediate postoperative morbidity and mortality: a single center study of 2606 patients. Obes Surg. 2009;19:1355–64.
Suter M, Calmes JM, Paroz A, et al. Results of Roux-en-Y gastric bypass in morbidly obese vs superobese patients. Arch Surg. 2009;144:312–8.
Rieu PN, Jansen JB, Biemond I, et al. Short-term results of gastrectomy with Roux-en-Y or Billroth II anastomosis for peptic ulcer. A prospective comparative study. Hepato-Gastroenterology. 1992;39(1):22–6.
Paroz A, Calmes JM, Giusti V, et al. Internal hernia after laparoscopic Roux-en-Y gastric bypass for morbid obesity: a continuous challenge in bariatric surgery. Obes Surg. 2006;16:1482–7.
Mason EE, Ito C. Gastric bypass in obesity. Surg Clin N Am. 1967;47:1345–135.
Chevallier JM, Trelles N, Arienzo R, et al. Endoscopic findings after laparoscopic omega loop gastric bypass. Obes Surg. 2011;21:956.
Garcia-Caballero M, Carbajo M. One anastomosis gastric bypass, safe and efficient surgical procedure for treating morbid obesity. Nutr Hosp. 2004;19(6):372–5.
Hampel H, Abraham NS, El-Serag HB. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med. 2005;143(3):199–211.
Erichsen R, Robertson D, Farkas DK, et al. Erosive reflux disease increases risk for esophageal adenocarcinoma, compared with non erosive reflux. Clin Gastroenterol Hepatol. 2012;10(5):475–80.
Korswagen LA, Schrama JG, Bruins Slot W, Hunfeld MA. Adenocarcinoma of the lower esophagus after placement of a gastric band. Obes Surg. 2009;19(3):389–392. 21.
Howard DD. Gastroesophageal reflux after sleeve gastrectomy in morbidly obese patients. Surg Obes Relat Dis. 2011;7(6):709–13.
Scozzari G, Trapani R, Toppino M, et al. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9:133–42.
Nishijima K, Miwa K, Miyashita T, et al. Impact of the biliary diversion procedure on carcinogenesis in Barrett’s esophagus surgically induced by duodenooesophageal reflux in rats. Ann Surg. 2004;240:57–67.
Frantz JD, Bretton G, Cartwright ME, et al. Proliferative lesions of the non-glandular and glandular stomach of rats . In: Guides for Toxicologic Pathology STP/ARF/AFIP, Washington,DC,1991.
Bassily R, Smallwood RA, Crotty B. Risk of gastric cancer is not increased after partial gastrectomy. J Gastroenterol Hepatol. 2000;15:762–5.
Csendes A, Burgos AM, Smok G, et al. Latest results (12–21 years) of a prospective randomized study comparing Billroth II and Roux-en-Y anastomosis after a partial gastrectomy plus vagotomy in patients with duodenal ulcers. Ann Surg. 2009;249:189–94.
Ito M, Takata S, Tatsugami M, et al. Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol. 2009;44:365–71.
Chun-Chi Wu, Wei-Jei Lee, Long-Han Ser, et al. Gastric cancer after mini-gastric bypass surgery: A case report and literature review. Asian J Endosc Surg. 2013;303–306.
Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354–62.
Brolin RE, Kenler HA, Gorman JH, et al. Long-limb gastric bypass in the superobese: a prospective randomized study. Ann Surg. 1992;215:387–95.
Kalfarentzos F, Skroubis G, Karamanakos S, et al. Biliopancreatic diversion with Roux-en-Y gastric bypass and long limbs: advances in surgical treatment for superobesity. Obes Surg. 2011;21:1849–58.
Padwal R, Klarenbach S, Wiebe N, et al. Bariatric surgery: a systematic review and network metaanalysis of randomized trials. Obes Rev. 2011;12:602–21.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Conflict of Interest
All the authors declare that they have no potential conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chevallier, J.M., Arman, G.A., Guenzi, M. et al. One Thousand Single Anastomosis (Omega Loop) Gastric Bypasses to Treat Morbid Obesity in a 7-Year Period: Outcomes Show Few Complications and Good Efficacy. OBES SURG 25, 951–958 (2015). https://doi.org/10.1007/s11695-014-1552-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11695-014-1552-z